New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
07:25 EDTRNA, RNA, RNAProsensa to host special shareholder meeting
Special shareholder meeting to appoint Dr. Georges Gemayel as new supervisory board member will be held on January 23 at 8 am.
News For RNA From The Last 14 Days
Check below for free stories on RNA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
07:00 EDTRNATerrapinn to hold a conference
Subscribe for More Information
April 21, 2014
15:39 EDTRNALeerink's biotech analyst holds an analyst/industry conference call
Biotech Analyst Schwartz, along with a Key Opinion Leader, discuss Sarepta's announcement that the Company will file a New Drug Application for Eteplirsen before the end of 2014 and Prosensa's drugs in development for Duchenne Muscular Dystrophy on an Analyst/Industry conference call to be held on April 22 at 12:45 pm.
12:35 EDTRNASarepta surges after plans for Muscular Dystrophy drug filing
Subscribe for More Information
09:21 EDTRNAOn The Fly: Pre-Market Movers
HIGHER: Sarepta (SRPT), up 54% after announcing plans to to submit NDA for Eteplirsen by year end 2014. Shares of Prosnesa (RNA), another drugmaker working on a competing DMD drug, are up more than 12%... AstraZeneca (AZN), up 6% after the Sunday Times says that Pfizer (PFE) is considering a takeover bid for the company. Pfizer is up 1.2% following the report... Newmont Mining (NEM), up 8% after WSJ says the company and Barrick Gold (ABX) could resume merger talks as soon as today... Cbeyond (CBEY), up 39% after agreeing to be acquired for about $323M by Birch Communications... Momenta Pharma (MNTA), up 10.5% after the Supreme Court rejected Teva's (TEVA) bid to delay generic Copaxone... Nu Skin (NUS), up 5% after saying its China division will resume corporate-hosted business meetings... Micron (MU), up 4% after price target raised at Drexel Hamilton... DOWN AFTER EARNINGS: Acacia Research (ACTG), down 6%... athenahealth (ATHN), down 5.6%.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use